1.
Record response to call for new astronauts
WASHINGTON, Dec. 3 (UPI) -- The U.S. Food and Drug Administration says it has approved a drug called Kalbitor to treat people suffering from hereditary angioedema.
The FDA said the rare genetic disease causes a sudden and potentially life-threatening fluid buildup due to a defect in a blood protein that helps regulate how certain immune system and blood clotting pathways function. Doctors said decreased function of the protein can lead to rapid and serious swelling of the face or other parts of the body, which may result in excruciating abdominal pain, nausea, permanent disfigurement, disability or death by suffocation.
Kalbitor (ecallantide) is the second drug marketed in the United States to treat the disease, the FDA said. Kalbitor is a liquid that is intended to be injected under the skin by a doctor for patients 16 and older.
The drug is marketed by the Dyax Corp. of Cambridge, Mass.
|
|
|
|
|
|
| Additional Science News Stories | |
WASHINGTON, Feb. 10 (UPI) --
A woman who says she had an affair with President John F. Kennedy wrote that she didn't feel at the time she was "invading the Kennedys' marriage."
|
MESA, Calif., Feb. 10 (UPI) --
Jesse Farrelly, the 20-year-old son of filmmaker Bobby Farrelly, has died in Costa Mesa, Calif., after a long battle with drug addiction, his family said.
|
ST. PETERSBURG, Russia, Feb. 10 (UPI) --
A water sample from Lake Vostok, hidden under Antarctic ice for millions of years, has been presented to Russia's Prime Minister Vladimir Putin, scientists say.
|
OTTAWA, Feb. 10 (UPI) --
A village in Canada with a population of 34 is disputing its disappearance as reported in Statistics Canada's census figures released this week.
|
| Stories | Photos | People | Comments |
View Caption
